Straits Times Index
3,344.03 -4.84 (-0.14%) Nikkei
38,875.34 -47.66 (-0.12%) Hang Seng
18,441.59 +38.59 (+0.21%) FTSE 100
8,262.75 -12.63 (-0.15%) Bitcoin USD
69,039.66 +564.14 (+0.82%) CMC Crypto 200
1,448.14 -19.80 (-1.35%)
EW Aug 2024 92.500 call
| Previous close | 2.5500 |
| Open | 3.1000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 92.50 |
| Expiry date | 2024-08-16 |
| Day's range | 2.5500 - 3.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
PR NewswireBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Edwards Lifesciences (NYSE: EW), today announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.
Business WireEdwards Lifesciences to Sell Critical Care to BD
IRVINE, CA, June 03, 2024--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.
ZacksWhy Is Idexx (IDXX) Up 5% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
